| Literature DB >> 30334554 |
Elias Tanuhadi1, Alexander Roller, Gerald Giester, Ioannis Kampatsikas, Annette Rompel.
Abstract
A novel synthetic pathway to obtain the first Zn6 hexagon tungstoantimonate [(Zn(H2O))6(B-α-SbW9O33)2]6- ([Zn6-α-SbW9] (1)) via rearrangement of a non-lacunary Krebs-POM precursor (C12N4H11)4K4[(Mn(H2O)3)2((Mn0.5W0.5)O2)2(B-β-SbW9O33)2] ([Mn-β-SbW9]) has been developed. Addition of ortho-phenylenediamine (opda) in order to optimize the synthesis of [Mn-β-SbW9] led to the crystallization of a novel Krebs-type Zn-POM (C12N4H11)4Na5[((Zn0.8W0.2)(H2O)3)2((Zn0.2W0.8)O2)2(B-β-SbW9O33)2] ([(Zn/W)2-β-SbW9] (2)) comprising four disordered Zn-centers after replacement of MnCl2 with ZnCl2. The compounds were characterized in the solid state by single-crystal and powder X-ray diffraction (XRD), IR spectroscopy, thermogravimetric analysis (TGA) and elemental analysis and in solution by UV-vis spectroscopy and ESI-mass spectrometry. The Krebs-POM archetype and the Zn6 hexagon tungstoantimonate have been investigated towards their interactions with Human Serum Albumin (HSA) as a model protein using SDS-PAGE and trypthophan fluorescence quenching.Entities:
Year: 2018 PMID: 30334554 PMCID: PMC6256361 DOI: 10.1039/c8dt02787k
Source DB: PubMed Journal: Dalton Trans ISSN: 1477-9226 Impact factor: 4.390
Fig. 1Polyhedral representation of [Zn6-α-SbW9] (1). Colour legend: WO6, pink; Sb, dark grey; Zn, silver; Ot, red.
Scheme 1Structure and synthesis of [Zn6-α-SbW9] (1) and [(Zn/W)2-β-SbW9] (2). The synthesis starts from the [SbW9] unit and the transition metal (TM) of choice. [Mn-β-SbW9] was used as precursor for the synthesis of the title compound, which was obtained by exchange of the manganese linker cations with zinc cations and β/α-isomerization of the precursor. Counter cations are omitted for clarity. Color legend: WO6, pink octahedra; 60° rotated WO6, ice blue octahedra; Sb, dark grey spheres; O, dark red spheres; Zn, light grey spheres; Mn, orange spheres; Cd, dark green spheres, W in the linking belt, dark blue spheres. Opda – o-phenylenediamine; 2,3-DAP – 2,3-diaminophenazine, ACN – acetonitrile.